Publication: Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders
Loading...
Program
relationships.isAuthorOf
Author
Kocaman, Gulsen
Kahraman, Nese
Gurkan Koseoglu, Banu
Matur, Zeliha
Gulsen, Yesim
Baykan Baykal, Betul
Advisor
Language
Type
Publisher
Journal Title
Journal ISSN
Volume Title
Abstract
Introduction: Migraine and temporomandibular disorders (TMD) are both common diseases and TMD are reported as a risk factor in migraine progression. OnabotulinumtoxinA is used in the treatment of chronic migraine (CM), and also has a potential role in TMD treatment. In this study, it is aimed to compare the efficacy of onabotulinumtoxinA treatment in CM patients with and without TMD.
Description
Source
Keywords
Keywords
Citation
Kocaman G., Kahraman N., Gurkan Koseoglu B., Bilgic B., Matur Z., Ertas M., Gulsen Y., Baykan Baykal B., -Evaluation of OnabotulinumtoxinA Treatment in Patients with Concomitant Chronic Migraine and Temporomandibular Disorders-, NOROPSIKIYATRI ARSIVI-ARCHIVES OF NEUROPSYCHIATRY, cilt.55, ss.330-336, 2018